Population Pharmacokinetics of Fasinumab in Healthy Volunteers and Patients With Pain Due to Osteoarthritis of the Knee or Hip

Documenti analoghi

• Target‐Mediated Modeling of Alirocumab in Adolescents and Children ≥8 to <12 Years of Age Using Phase II and III Data
  di: Pavel Kovalenko, et al.
  Pubblicazione: (2025)
• Pharmacokinetics and Bioequivalence of Vardenafil Hydrochloride in Healthy Chinese Volunteers
  di: Sheng He, et al.
  Pubblicazione: (2024)
• Bioequivalence and Pharmacokinetic Evaluation of Regorafenib Tablets in Healthy Chinese Volunteers
  di: Zhaoyu Wang, et al.
  Pubblicazione: (2024)
• Population Pharmacokinetic and Pharmacodynamic Modeling of Romiplostim Biosimilar GP40141 and Reference Product in Healthy Volunteers to Evaluate Biosimilarity
  di: Igor Makarenko, et al.
  Pubblicazione: (2024)
• Pharmacokinetics, Bioequivalence, and Safety Evaluation of Two Voriconazole Tablets in Healthy Chinese Volunteers
  di: Pan Luo, et al.
  Pubblicazione: (2026)